Regents of the University of California’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,678
| Closed | -$28.7K | – | 29 |
|
|
2023
Q4 | $28.7K | Hold |
2,678
| – | – | ﹤0.01% | 27 |
|
|
2023
Q3 | $16.2K | Hold |
2,678
| – | – | ﹤0.01% | 28 |
|
|
2023
Q2 | $18.5K | Hold |
2,678
| – | – | ﹤0.01% | 29 |
|
|
2023
Q1 | $42K | Hold |
2,678
| – | – | 0.01% | 29 |
|
|
2022
Q4 | $53.6K | Hold |
2,678
| – | – | 0.01% | 34 |
|
|
2022
Q3 | $48K | Hold |
2,678
| – | – | 0.01% | 37 |
|
|
2022
Q2 | $59K | Buy |
+2,678
| New | +$59K | 0.01% | 34 |
|